C12N 2770/24121
Viruses as such
Official title: Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N2770/24121 (Viruses as such) appears on 77 US grants and 116 published applications in this corpus.
Search patents in C12N- Granted patents
- 77
- Published applications
- 116
- Assignees
- 91
- Inventors
- 269
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 2 |
| 2006 | 1 | 3 |
| 2007 | 1 | 1 |
| 2008 | 1 | 0 |
| 2009 | 1 | 4 |
| 2010 | 4 | 4 |
| 2011 | 5 | 4 |
| 2012 | 2 | 5 |
| 2013 | 1 | 1 |
| 2014 | 6 | 6 |
| 2015 | 2 | 3 |
| 2016 | 3 | 3 |
| 2017 | 3 | 3 |
| 2018 | 4 | 6 |
| 2019 | 4 | 14 |
| 2020 | 6 | 13 |
| 2021 | 7 | 13 |
| 2022 | 8 | 6 |
| 2023 | 4 | 7 |
| 2024 | 7 | 10 |
| 2025 | 3 | 7 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Live-attenuated flaviviruses with heterologous antigens22 Sep 2026US 12,741,991 B2Katholieke Universiteit Leuven
- DNA plasmid-launched live-attanuated vaccines for plus-sense singel stranded RNA15 Jul 2025US 12,357,682 B2Board of Regents, The University of Texas System
- Attenuating viral mutations in protein genes3 Jun 2025US 12,318,439 B2Board of Regents, The University of Texas System
- Zika virus strains for treatment of glioma15 Apr 2025US 12,274,725 B2Board of Regents, The University of Texas System
- Attenuated flaviviruses17 Dec 2024US 12,168,049 B2Codagenix Inc.
- Infectious full-length clone of zika virus or variant thereof and use thereof6 Nov 2025US 2025/0340850 A1RpexBio, Inc.
- Self-amplifying mrna vaccine based on z7 genome14 Aug 2025US 2025/0255952 A1The University of Southern Mississippi
- Oncolytic viruses and methods of use15 May 2025US 2025/0154509 A1Vyro Bio Inc.
- Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development24 Apr 2025US 2025/0127871 A1The University of North Carolina at Chapel Hill
- Vaccines against infectious diseases caused by positive stranded rna viruses20 Feb 2025US 2025/0057932 A1Medigen, Inc.
Most cited
By later US patents
- Avirulent, immunogenic flavivirus chimeras29US 7,094,411 B2The United States of America as represented by the Department of Health and Human Services · 2006
- Avirulent, immunogenic flavivirus chimeras21US 8,673,316 B2Mahidol University · 2014
- Yellow fever infectious cDNA and plasmids20US 6,171,854 B2Fundaco Oswaldo Cruz-Fiocruz · 2001
- Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses11US 7,226,602 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2007
- Chromatography based purification strategies for viruses10US 10,894,079 B2Themis Bioscience GmbH · 2021